LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing,Cyclopentanohydrophenanthrene ring system doai

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

11.beta.-substituted 16.alpha., 17.alpha.-methylene-estra-4,9-di

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

13-alkyl-11.beta.-phenylgonanes

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

13-alkyl-11beta-phenylgonanes

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

13.alpha.-alkyl-gonanes, their production, and pharmaceutical pr

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

14 β, 16, 17-methylene steroids as novel androgens

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

14&bgr;,15&bgr;-methylene-17&agr;-hydroxymethyl-androgens

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

14, 15-.&agr;.-methylene equilenine derivatives, methods for...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

14, 15-cyclopropanosteroids of the 19-norandrostane series,...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

14,16.beta.-ethano-15.beta., 16(1)-cyclo-14.beta.-estra-1,3,5(10

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

14,17.alpha.-etheno- and -ethanoestratrienes, processes for the

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

14,17.beta.-ethano-14.beta.-estratrienes and estratetraenes, pro

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

14-β, 17-α-hydroxymethylandrostane derivatives...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

14-.alpha., 17-.alpha.-C.sub.2 bridged norprogesterone derivativ

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

14-aminosteroid derivatives, application in therapy and process

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

14-deoxy-14.alpha.-cardenolides 3.beta.-thioderivatives and phar

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

14.alpha., 16.alpha.-ethanoand 14.alpha., 16.alpha.-etheno-estra

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

14.alpha., 17.alpha.-C.sub.2 -bridged norprogesterone derivative

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

14.alpha., 17.alpha.-ethano-16.alpha.-hydroxy-estratrienes

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

14.alpha.,17.alpha.-ethanoestratrienes